Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Banco de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Clin Exp Ophthalmol ; 38(6): 620-8, 2010 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-20584023

RESUMEN

BACKGROUND: Transforming growth factor beta (TGF-beta) plays an important role in diabetic retinopathy. betaIG-H3 is a downstream target molecule of TGF-beta that may participate in the pathogenesis of diabetic retinopathy and in particular in the loss of pericytes during early pathological changes. METHODS: We observed bovine retinal pericytes apoptosis and the increased expression of TGF-beta and betaIG-H3 induced by high concentrations of glucose in the cell culture media. An anti-TGF-beta antibody was used to block glucose-induced retinal pericytes apoptosis. Retinal pericytes were also transfected with cDNA encodings either wild-type or mutant betaIG-H3 lacking Arg-Gly-Asp (RGD) sequences in order to validate the effects of betaIG-H3 and RGD signalling on retinal pericytes apoptosis. RESULTS: A cell death-detecting enzyme-linked immunosorbent assay revealed that 25 mM glucose significantly increased cell death compared with 5.5 mM glucose after 5 or 7 days of exposure (P < 0.01). High glucose significantly increased the TGF-beta levels as compared with 5.5 mM glucose after 5 days, and betaIG-H3 levels after 3, 5 and 7 days of exposure (P < 0.01). TGF-beta increased cell death and betaIG-H3 levels in a dose-dependent manner, with a maximal effect observed at 1 ng/mL. An anti-TGF-beta antibody nearly completely blocked high glucose-induced cell death. Wild-type betaIG-H3-transfected cells showed a significant increase in cell death as compared with mutant betaIG-H3-transfected (Mycb-c) cells, untransfected or mock-transfected cells. CONCLUSION: These results suggest that hyperglycaemia-induced expression of TGF-beta and betaIG-H3 contributes to accelerated retinal pericytes apoptosis. betaIG-H3 induces pericytes apoptosis through its RGD motif, which may constitute an important pathogenic mechanism leading to pericytes loss in diabetic retinopathy.


Asunto(s)
Apoptosis/efectos de los fármacos , Proteínas de la Matriz Extracelular/metabolismo , Glucosa/farmacología , Oligopéptidos/metabolismo , Pericitos/patología , Factor de Crecimiento Transformador beta/metabolismo , Animales , Bovinos , Supervivencia Celular , Células Cultivadas , Ensayo de Inmunoadsorción Enzimática , Proteínas de la Matriz Extracelular/genética , Glucosa/antagonistas & inhibidores , Inmunoglobulina G/farmacología , Etiquetado Corte-Fin in Situ , Pericitos/metabolismo , Vasos Retinianos/patología , Transfección , Factor de Crecimiento Transformador beta/genética , Factor de Crecimiento Transformador beta/inmunología
2.
Cancer Cell ; 26(5): 653-67, 2014 Nov 10.
Artículo en Inglés | MEDLINE | ID: mdl-25517748

RESUMEN

We isolated and analyzed, at single-nucleotide resolution, cancer-associated neochromosomes from well- and/or dedifferentiated liposarcomas. Neochromosomes, which can exceed 600 Mb in size, initially arise as circular structures following chromothripsis involving chromosome 12. The core of the neochromosome is amplified, rearranged, and corroded through hundreds of breakage-fusion-bridge cycles. Under selective pressure, amplified oncogenes are overexpressed, while coamplified passenger genes may be silenced epigenetically. New material may be captured during punctuated chromothriptic events. Centromeric corrosion leads to crisis, which is resolved through neocentromere formation or native centromere capture. Finally, amplification terminates, and the neochromosome core is stabilized in linear form by telomere capture. This study investigates the dynamic mutational processes underlying the life history of a special form of cancer mutation.


Asunto(s)
Cromosomas Humanos/genética , Liposarcoma/genética , Neoplasias Retroperitoneales/genética , Anciano , Carcinogénesis/genética , Línea Celular Tumoral , Centrómero/genética , Aberraciones Cromosómicas , Femenino , Humanos , Liposarcoma/patología , Modelos Genéticos , Mutagénesis , Oncogenes , Neoplasias Retroperitoneales/patología , Translocación Genética
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA